GSK2973980A is primarily investigated for its potential therapeutic applications in the treatment of various medical conditions. It is being studied for its role in targeting specific biological pathways that are implicated in disease processes. Research suggests it may have applications in managing inflammatory disorders, where it could modulate immune responses to reduce inflammation and associated symptoms. Additionally, its potential use in oncology is being explored, as it may inhibit pathways involved in tumor growth and survival. Early-phase clinical trials are assessing its efficacy and safety, aiming to determine its suitability for broader therapeutic use in patients. Further studies are required to fully understand its mechanisms and optimize its application in clinical settings.